On March 19, 2025, the U.S. Food and Drug Administration reported an incident involving the detention of dietary supplements and unconventional specialty products for humans and animals. This action was prompted by the refusal of certain foreign establishments to submit to FDA inspections.
The products in question encompass a diverse range of dietary supplements and unconventional specialties, originating from China. These items have been identified for detention without physical examination due to compliance issues related to FDA inspection protocols.
This incident falls under the category of control, highlighting the FDA's ongoing commitment to ensuring the safety and compliance of food products entering the United States. The refusal to undergo inspection poses significant concerns regarding the regulatory standards set forth by the agency.
As the situation develops, the FDA continues to monitor the compliance of foreign establishments to safeguard public health and ensure that all dietary supplements and animal products meet established safety standards.